EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from January 12, 2026, to January 16, 2026 (each inclusive), 840,383 shares were bought back within the framework of the second tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on January 12, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
12 January 2026	93,000	40.5248	3,768,806.40	XETR
13 January 2026	160,000	39.8680	6,378,880.00	XETR
14 January 2026	180,000	37.3359	6,720,462.00	XETR
15 January 2026	40,000	36.7086	1,468,344.00	CEUX
15 January 2026	172,383	36.7050	6,327,318.02	XETR
16 January 2026	27,500	37.2218	1,023,599.50	CEUX
16 January 2026	167,500	37.2219	6,234,668.25	XETR

A total of 840,383 shares has been acquired within the framework of the second tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.